Fisher Asset Management
ALXN

Fisher Asset Management’s Alexion Pharmaceuticals ALXN Stock Holding History

Fisher Asset Management’s Portfolio ALXN Stock Details ALXN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-3,001
Closed -$469K – 982
2020
Q4 		$469K Sell
3,001
-20,273
-87% -$2.61M ﹤0.01% 719
2020
Q3 		$2.66M Buy
23,274
+526
+2% +$56.7K ﹤0.01% 450
2020
Q2 		$2.55M Sell
22,748
-7,074
-24% -$751K ﹤0.01% 460
2020
Q1 		$2.68M Buy
29,822
+16,687
+127% +$1.64M ﹤0.01% 415
2019
Q4 		$1.42M Buy
13,135
+331
+3% +$35.4K ﹤0.01% 542
2019
Q3 		$1.25M Sell
12,804
-35
-0.3% -$3.94K ﹤0.01% 595
2019
Q2 		$1.68M Buy
+12,839
New +$1.65M ﹤0.01% 562

Other funds holding ALXN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $15.3B AUM 50.95% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $7.94B AUM 55.6% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $14.1B AUM 58.13% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
DKCM
Davidson Kempner Capital Management New York $4.65B AUM 56.47% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return